Familial Transthyretin Amyloidosis Latest Advances
Find the Latest Research About Familial Transthyretin Amyloidosis
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3248 publications
ATTR-CM: What do we know about blood levels of the TTR protein? A discussion with experts.
Journal: Therapeutic advances in cardiovascular disease
Published: April 02, 2026
Central Nervous System Manifestations Associated with Hereditary Transthyretin Amyloidosis: a Narrative Review.
Journal: Arquivos de neuro-psiquiatria
Published: March 23, 2026
A case of hereditary transthyretin amyloidosis cardiomyopathy complicated with monoclonal gammopathy of undetermined significance
Journal: Zhonghua xin xue guan bing za zhi
Published: March 22, 2026
Prevalence and Prognostic Significance of Restriction Versus Systolic Dysfunction in Patients With Transthyretin and Light Chain Cardiac Amyloidosis.
Journal: Circulation. Heart failure
Published: February 24, 2026
In memoriam: Shukuro Araki, MD, PhD (1927-2025) pioneer of Japanese neurology and a global leader in familial amyloid polyneuropathy.
Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
Published: February 16, 2026
Expert consensus on multidisciplinary collaborative screening and diagnostic pathway for transthyretin amyloidosis
Journal: Zhonghua xin xue guan bing za zhi
Published: February 13, 2026
Acoramidis in transthyretin amyloid cardiomyopathy: expanding evidence from ATTRibute-CM.
Journal: Future cardiology
Published: February 09, 2026
Attenuated peripheral vascular responsiveness contributes to baroreflex dysfunction in patients with wild-type transthyretin amyloidosis.
Journal: American journal of physiology. Heart and circulatory physiology
Published: January 30, 2026
Application of Omics Analysis in the Clinical Practice and Research of Transthyretin Amyloidosis.
Journal: Genes
Published: January 29, 2026
Transthyretin Amyloid Cardiomyopathy: A Rapidly Evolving Landscape.
Journal: Annual review of medicine
Published: January 27, 2026
Proteomics Profiling Reveals Circulating Biomarkers and Dysregulated Pathways in Transthyretin Amyloid Cardiomyopathy.
Journal: Circulation. Heart failure
Published: January 22, 2026
2025 New Drug Update (Part 2): Recent Approvals and Clinical Implications.
Journal: The Senior care pharmacist
Published: January 20, 2026
Last Updated: 04/28/2026